JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265003

Human DSTYK (RIPK5) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

DSTYK KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 1 bp insertion in exon 1 and 5 bp deletion in exon 1.

View Alternative Names

DSTYK, DUSTY_HUMAN, Dual serine/threonine and tyrosine protein kinase, Dusty PK, Dusty protein kinase, HDCMD38P, KIAA0472, RIP-homologous kinase, RIP5, Receptor interacting protein 5, Receptor interacting protein kinase 5, Receptor-interacting serine/threonine-protein kinase 5, SgK496, Sugen kinase 496

3 Images
Sanger Sequencing - Human DSTYK (RIPK5) knockout HeLa cell line (AB265003)
  • Sanger seq

Unknown

Sanger Sequencing - Human DSTYK (RIPK5) knockout HeLa cell line (AB265003)

Allele-1 : 5 bp deletion in exon 1.

Sanger Sequencing - Human DSTYK (RIPK5) knockout HeLa cell line (AB265003)
  • Sanger seq

Unknown

Sanger Sequencing - Human DSTYK (RIPK5) knockout HeLa cell line (AB265003)

Allele-2 : 1 bp deletion in exon 1.

Sanger Sequencing - Human DSTYK (RIPK5) knockout HeLa cell line (AB265003)
  • Sanger seq

Unknown

Sanger Sequencing - Human DSTYK (RIPK5) knockout HeLa cell line (AB265003)

Allele-3 : 1 bp insertion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 1 bp insertion in exon 1 and 5 bp deletion in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255448). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265003-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265003 Human DSTYK (RIPK5) knockout HeLa cell line", "number":"AB265003-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265003-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265003 Human DSTYK (RIPK5) knockout HeLa cell line", "number":"AB265003-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
DSTYK
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

RIPK5 also known as Receptor-Interacting Protein Kinase 5 is an important signaling molecule with a molecular mass of approximately 78 kDa. It belongs to the RIP kinase family characterized by a serine/threonine kinase domain. RIPK5 is expressed in a diverse range of tissues with higher expression levels noted in the brain and spleen. This distribution suggests a role in both neural function and immune response.
Biological function summary

RIPK5 functions as part of a larger protein complex involved in cellular stress responses. It contributes to the modulation of apoptosis and necroptosis two forms of programmed cell death. While RIPK5 itself does not initiate these processes its kinase activity modifies other proteins in the complex altering their function and the outcome of cell death pathways. This highlights RIPK5's integrative role in maintaining cellular homeostasis.

Pathways

RIPK5 participates in key signaling networks like the TNF receptor and NF-κB pathway. It interacts closely with proteins such as TAK1 and TRAF2 mediating downstream signaling cascades that affect inflammation and immune response. Through these interactions RIPK5 can influence cell survival differentiation and inflammatory responses impacting various physiological processes.

Research has linked RIPK5 to neurological disorders such as Alzheimer's disease and Parkinson's disease. Its association with proteins like tau and α-synuclein in these conditions suggests a potential role in neurodegeneration possibly through pathways that misregulate cell death or inflammatory responses. Understanding RIPK5's involvement in these diseases could provide insight into disease progression and opportunities for therapeutic interventions.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com